Imvax Announces Completion of Enrollment in Phase 2b Clinical Trial of IGV-001
Imvax, a national sponsor for Head for the Cure, has made significant strides in cancer research, recently announcing the completion of enrollment in their Phase 2b clinical trial of IGV-001. This milestone, coupled with successful